SCHEMBL18464129

SCHEMBL18464129

Cc1ccc2cc(-c3ccc(-c4ccc(-c5ccc(-c6ccc7cc(C)ccc7c6)cc5F)c5nsnc45)c(F)c3)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 3/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ PDE3B Q13370 3/20 0.38
▸ PDE3A Q14432 3/20 0.38
▸ ESR1 P03372 4/20 0.37
▸ ESR2 Q92731 4/20 0.37
▸ TDP1 Q9NUW8 1/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ NR3C1 P04150 1/20 0.33
▸ GRM2 Q14416 1/20 0.33
▸ APP P05067 1/20 0.33
▸ CCR1 P32246 1/20 0.33
▸ CCR5 P51681 1/20 0.33
▸ CCR8 P51685 1/20 0.33
▸ HSD11B1 P28845 1/20 0.32
▸ RPS6KA3 P51812 2/20 0.32
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21537531 0.92 PDE3B (0.34) CYP2A6CYP1A2PDE3BPDE3AESR1
SCHEMBL21537510 0.88 PDE3B (0.38) PDE3BPDE3ADHODHRPS6KA3SMN1; SMN2
SCHEMBL21935453 0.86 PDE3B (0.38) PDE3BPDE3ADHODHGRM2RPS6KA3
SCHEMBL18464809 0.84 CYP1A2 (0.46) CYP2A6CYP1A2ESR1ESR2TDP1
SCHEMBL25070289 0.83 HSD17B1 (0.47) CYP1A2AKR1C3AKR1C2CYP3A4CYP2C9
SCHEMBL18464324 0.82 DHODH (0.44) CYP1A2PDE3BPDE3ATDP1DHODH
SCHEMBL18464325 0.80 DHODH (0.46) PDE3BPDE3ADHODHGRM2SMN1; SMN2
SCHEMBL18464327 0.80 ESR1 (0.39) PDE3BPDE3AESR1ESR2DHODH
SCHEMBL20647415 0.80 PDE3B (0.39) PDE3BPDE3ADHODHAPPRPS6KA3
SCHEMBL22055031 0.79 ESR1 (0.49) CYP2A6CYP1A2PDE3BPDE3AESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230053362-A1 DICHROIC DYE COMPOSITION MERCK PATENT GMBH (DE) 2023-02-23 — — US disclosed
US-11015123-B2 Liquid-crystal material MERCK PATENT GMBH (DE) 2021-05-25 — — US disclosed
US-20200255741-A1 LIQUID-CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2020-08-13 — — US disclosed
US-10723950-B2 Liquid-crystalline mixtures MERCK PATENT GMBH (DE) 2020-07-28 — — US disclosed
EP-3458549-B1 LIQUID-CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2020-07-22 — — EP disclosed
EP-3400271-B1 LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2020-07-22 — — EP disclosed
US-10344217-B2 Device for controlling the passage of energy, containing a dichroic dye compound MERCK PATENT GMBH (DE) 2019-07-09 — — US disclosed
US-10260001-B2 Liquid crystal material MERCK PATENT GMBH (DE) 2019-04-16 — — US disclosed
US-20190016955-A1 LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2019-01-17 — — US disclosed
US-20170029702-A1 LIQUID CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2017-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10344217-B2 Device for controlling the passage of energy, containing a dichroic dye compound CRY1, SLC25A1, CRY2 CYP2A6 4037/4885CYP1A2 2025/4885PDE3B 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback